[1] |
Becerra-Ruiz JS, Guerrero-Velázquez C, Martínez-Esquivias F, et al. Innate and adaptive immunity of periodontal disease. From etiology to alveolar bone loss[J]. Oral Dis, 2022, 28(6): 1441-1447.
|
[2] |
Hajishengallis G. Periodontitis: From microbial immune subversion to systemic inflammation[J]. Nat Rev Immunol, 2015, 15(1): 30-44.
|
[3] |
Khassawneh B, Alhabashneh R, Ibrahim F. The association between bronchial asthma and periodontitis: A case-control study in Jordan[J]. J Asthma, 2019, 56(4): 404-410.
|
[4] |
Fatima Z, Shahzadi C, Nosheen A, et al. Periodontitis is a risk factor in developing cardiovascular diseases[J]. J Pak Med Assoc, 2020: 1-8.
|
[5] |
Ono T, Nakashima T. Recent advances in osteoclast biology[J]. Histochem Cell Biol, 2018, 149(4): 325-341.
|
[6] |
李琴, 王佐林. TREM-2/DAP12复合物在牙周炎中的作用及研究进展[J]. 口腔颌面外科杂志, 2021, 31(2): 110-113.
|
[7] |
Tanaka Y, Nakayamada S, Okada Y. Osteoblasts and osteoclasts in bone remodeling and inflammation[J]. Curr Drug Target Inflamm Allergy, 2005, 4(3): 325-328.
|
[8] |
Blottière L, Apiou F, Ferbus D, et al. Cloning, characterization, and chromosome assignment of Zfp146 the mouse ortholog of human ZNF146 a gene amplified and overexpressed in pancreatic cancer, and Zfp260 a closely related gene[J]. Cytogenet Cell Genet, 1999, 85(3-4): 297-300.
|
[9] |
Chen K, Zhang N, Shao JB, et al. Allogeneic hematopoietic stem cell transplantation for PEX1-related zellweger spectrum disorder: A case report and literature review[J]. Front Pediatr, 2021, 9: 672187.
|
[10] |
Komati H, Maharsy W, Beauregard J, et al. ZFP260 is an inducer of cardiac hypertrophy and a nuclear mediator of endothelin-1 signaling[J]. J Biol Chem, 2011, 286(2): 1508-1516.
|
[11] |
Jurado Acosta A, Rysä J, Szabo Z, et al. Transcription factor PEX1 modulates extracellular matrix turnover through regulation of MMP-9 expression[J]. Cell Tissue Res, 2017, 367(2): 369-385.
|
[12] |
Li J, Jin F, Cai M, et al. LncRNA nron inhibits bone resorption in periodontitis[J]. J Dent Res, 2022, 101(2): 187-195.
|
[13] |
Kim JM, Lin CJ, Stavre Z, et al. Osteoblast-osteoclast communication and bone homeostasis[J]. Cells, 2020, 9(9): 2073.
|
[14] |
Uenaka M, Yamashita E, Kikuta J, et al. Osteoblast-derived vesicles induce a switch from bone-formation to bone-resorption in vivo[J]. Nat Commun, 2022, 13(1): 1066.
|
[15] |
Chen X, Wang ZQ, Duan N, et al. Osteoblast-osteoclast interactions[J]. Connect Tissue Res, 2018, 59(2): 99-107.
|
[16] |
Li WJ, Xie HL, Hu H, et al. PEX1 is a mediator of α1-adrenergic signaling attenuating doxorubicin-induced cardiotoxicity[J]. J Biochem Mol Toxicol, 2022, 36(11): e23196.
|
[17] |
Debrus S, Rahbani L, Marttila M, et al. The zinc finger-only protein Zfp260 is a novel cardiac regulator and a nuclear effector of alpha1-adrenergic signaling[J]. Mol Cell Biol, 2005, 25(19): 8669-8682.
|
[18] |
Jurado Acosta A, Rysä J, Szabo Z, et al. Transcription factor PEX1 modulates extracellular matrix turnover through regulation of MMP-9 expression[J]. Cell Tissue Res, 2017, 367(2): 369-385.
|
[19] |
Kaur S, Bansal Y, Kumar R, et al. A panoramic review of IL-6: Structure, pathophysiological roles and inhibitors[J]. Bioorg Med Chem, 2020, 28(5): 115327.
|
[20] |
Garbers C, Aparicio-Siegmund S, Rose-John S. The IL-6/gp130/STAT3 signaling axis: Recent advances towards specific inhibition[J]. Curr Opin Immunol, 2015, 34: 75-82.
|
[21] |
Kang WY, Shang LL, Wang T, et al. Rho-kinase inhibitor Y-27632 downregulates LPS-induced IL-6 and IL-8 production via blocking p38 MAPK and NF-κB pathways in human gingival fibroblasts[J]. J Periodontol, 2018, 89(7): 883-893.
|